PEGS: IMPROVING ANALYSIS OF QUALITY INDICATING ATTRIBUTES FOR BETTER LIFECYCLE MANAGEMENT

Significance of the Topic

Effective monitoring of quality-indicating attributes in biopharmaceutical products is essential to ensure safety and efficacy throughout the drug lifecycle. Analytical methods that evolve with technological advances help maintain regulatory compliance and support continual process optimization by detecting critical modifications and impurities in therapeutic proteins.

Objectives and Study Overview

This study aimed to migrate a reversed-phase LC/MS peptide mapping assay for a mAb digest from a conventional “Legacy” LC system to a “Bioinert” LC system. The goals were to demonstrate method equivalency in retention time and peak area, and to quantify improvements in peak tailing and recovery for peptides, particularly those with metal-sensitive acidic residues.

Methodology and Instrumentation

Sample preparation involved tryptic digestion of NIST mAb RM 8671. Chromatographic separations were performed on:

• Legacy System: ACQUITY UPLC Classic with CSH C18 column (1.7 µm, 2.1×100 mm)
• Bioinert System: ACQUITY Premier with Peptide CSH C18 column (1.7 µm, 2.1×100 mm)

Both systems used identical fixed-loop injections (5 µL), UV detection at 214 nm, and QDa mass detection under positive scan (m/z 350–1250). Gradient elution stood at 0.2 mL/min over 80 min, with formic acid in water and acetonitrile as mobile phases.

Main Results and Discussion

The bioinert LC system exhibited a closely matched dwell volume to the legacy system (158.8 µL vs. 149.4 µL), enabling direct method transfer without dwell adjustments. Retention times correlated linearly across platforms (intercept = 0.003 min), and peak areas differed by less than 0.5%.

Notably, peptides containing two to four acidic residues showed up to 70% reduction in peak tailing and three-fold higher recovery on the bioinert system. The higher sensitivity allowed detection of low-abundance acidic species, such as the deamidated variant of a critical “penny” peptide, which was not observed on the legacy system.

Benefits and Practical Applications

The migration to bioinert hardware delivered:

• Improved chromatographic performance for metal-sensitive analytes
• Enhanced recovery and sharper peaks for acidic peptides
• Seamless transfer of existing methods without reoptimization
• Greater confidence in characterization of critical quality attributes

These advantages support robust quality control in biologics development and manufacturing.

Future Trends and Applications

Advances in surface treatments and hardware design will continue to reduce nonspecific adsorption and improve assay sensitivity. Integration of bioinert platforms with high-resolution MS and automation can further streamline peptide mapping workflows. Expanding these innovations to other classes of biomolecules and impurities will drive broader adoption in regulated environments.

Conclusion

The study confirmed that a bioinert LC system provides equivalent retention and quantitation to a conventional LC while significantly reducing peak tailing and boosting recovery for acidic peptides. This migration enhances assay performance, facilitates regulatory compliance, and strengthens lifecycle management of biotherapeutics.